Vault-13

BOONE CAPITAL MANAGEMENT LLC

ATLANTA, GA · CIK 1882053 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2022 · limited liability company

As an employer

$427.5m reported value +31.0% vs Q1 2026
16positions
83.0%in top 10
7 new 8 added 1 reduced 4 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 TELEFLEX INCORPORATED COM TFX TFX 387,388 $49.1m11.49% 11.49% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 278.8k, Q2 2026 387.4k +108.6k +108,596 39.0%
2 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 415,641 $48.7m11.38% 11.38% ReducedShares held: Q3 2025 535.7k, Q4 2025 421.2k, Q1 2026 421.2k, Q2 2026 415.6k -5.6k -5,595 -1.3%
3 THE CIGNA GROUP COM CI CI 159,290 $43.9m10.27% 10.27% AddedShares held: Q3 2025 83.0k, Q4 2025 96.5k, Q1 2026 137.5k, Q2 2026 159.3k +21.8k +21,768 15.8%
4 IONIS PHARMACEUTICALS INC COM IONS IONS 519,977 $41.2m9.64% 9.64% AddedShares held: Q3 2025 417.8k, Q4 2025 417.8k, Q1 2026 500.5k, Q2 2026 520.0k +19.5k +19,455 3.9%
5 UNITEDHEALTH GROUP INC COM UNH UNH 88,687 $36.9m8.62% 8.62% AddedShares held: Q3 2025 58.1k, Q4 2025 61.8k, Q1 2026 79.2k, Q2 2026 88.7k +9.5k +9,461 11.9%
6 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 583,219 $33.4m7.81% 7.81% AddedShares held: Q3 2025 328.5k, Q4 2025 411.9k, Q1 2026 547.9k, Q2 2026 583.2k +35.3k +35,348 6.5%
7 GUARDIAN PHARMACY SVCS INC CL A GRDN GRDN 711,939 $29.8m6.97% 6.97% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 631.2k, Q2 2026 711.9k +80.7k +80,746 12.8%
8 VESTIS CORPORATION COM SHS VSTS VSTS 1,900,140 $27.6m6.45% 6.45% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.9m
9 BRIDGEBIO PHARMA INC COM BBIO BBIO 339,720 $25.3m5.92% 5.92% AddedShares held: Q3 2025 460.3k, Q4 2025 185.0k, Q1 2026 228.8k, Q2 2026 339.7k +110.9k +110,891 48.5%
10 PENNANT GROUP INC COM PNTG PNTG 515,818 $19.1m4.46% 4.46% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 515.8k
11 MONTE ROSA THERAPEUTICS INC COM GLUE GLUE 615,287 $14.9m3.48% 3.48% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 615.3k
12 KODIAK SCIENCES INC COM KOD KOD 378,010 $14.7m3.44% 3.44% AddedShares held: Q3 2025 715.9k, Q4 2025 503.8k, Q1 2026 281.3k, Q2 2026 378.0k +96.7k +96,678 34.4%
13 TANGO THERAPEUTICS INC COM TNGX TNGX 455,605 $14.2m3.33% 3.33% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 455.6k
14 KYMERA THERAPEUTICS INC COM KYMR KYMR 113,173 $13.0m3.04% 3.04% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 113.2k
15 CULLINAN THERAPEUTICS INC COM CGEM CGEM 704,442 $12.8m3.00% 3.00% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 704.4k
16 ADLAI NORTYE LTD SPONSORED ADS ANL ANL 258,390 $3.0m0.70% 0.70% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 258.4k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
MEDTRONIC PLC MDT MDT 398,065 $34.5m398.1k shares
ASTRAZENECA PLC AZN AZN 110,101 $21.7m110.1k shares
AVANOS MED INC AVNS AVNS 1,184,909 $16.6m1.2m shares
TENAX THERAPEUTICS INC TENX TENX 200,000 $3.2m200.0k shares